Skip to main content

Irritable Bowel Syndrome

  • Chapter
  • First Online:
Fibromyalgia
  • 1965 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders. 2007;8:27.

    Article  PubMed  Google Scholar 

  2. Almansa C, Rey E, Sánchez RG, Sánchez AA, Díaz-Rubio M. Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress. Clin Gastroenterol Hepatol. 2009;7:438–45.

    Article  PubMed  Google Scholar 

  3. Pamuk ON, Umit H, Harmandar O. Increased frequency of gastrointestinal symptoms in patients with fibromyalgia and associated factors: a comparative study. J Rheumatol. 2009;36:1720–4.

    Article  PubMed  Google Scholar 

  4. Rome III. Rome Foundation website: http://www.romecriteria.org/ (Accessed March 2008.)

  5. Halder SL, Locke GR, Schleck CD, et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133:799–807.

    Article  PubMed  Google Scholar 

  6. Hungin AS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003;17:643–50.

    Article  PubMed  CAS  Google Scholar 

  7. Gómez Alvarez DF, Morales Vargas JG, Rojas Medina LM, et al. Prevalence of irritable bowel syndrome and associated factors according to the Rome III diagnostic criteria in a general population in Colombia. Gatroenterol Hepatol. 2009;32:395–400.

    Article  Google Scholar 

  8. Faresjö A, Grodzinsky E, Johansson S, et al. A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome – women are more seriously affected than men. Am J Gastroenterol. 2007;102:371–9.

    Article  PubMed  Google Scholar 

  9. Riedl A, Schmidtmann M, Stengel A, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res. 2008;64:573–82.

    Article  PubMed  Google Scholar 

  10. Moshiree B, Price DD, Robinson ME, Gaible R, Verne GN. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain. 2007;23:323–30.

    Article  PubMed  Google Scholar 

  11. Olden KW. The challenge of diagnosing irritable bowel syndrome. Rev Gastroenterol Dis. 2003;3:S3–11.

    Google Scholar 

  12. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004;53:666–72.

    Article  PubMed  CAS  Google Scholar 

  13. Videlock EJ, Chang L. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol Clin N Am. 2007;36:665–85.

    Article  Google Scholar 

  14. Holten KB. Irritable bowel syndrome: minimize testing, let symptoms guide treatment. J Fam Pract. 2003;52:942–9.

    Google Scholar 

  15. Spanier JA, Howden CW, Jones MP. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med. 2003;163:265–74.

    Google Scholar 

  16. Reitblat T, Zamir D, Polishchuck I, et al. Patients treated by tegaserod for irritable bowel syndrome with constipation showed significant improvement in fibromyalgia symptoms. A pilot study. Clin Rheumatol. 2009;29:1079–82.

    Article  Google Scholar 

  17. Owen RT. Lubiprostone – a novel treatment for irritable bowel syndrome with constipation. Drugs Today (Barc). 2008;44:645–52.

    Article  CAS  Google Scholar 

  18. Lacy BE, Chey WD. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation. Expert Opin Pharmacother. 2009;10:143–52.

    Article  PubMed  CAS  Google Scholar 

  19. Drossman DA, Chey WD, Johanson JF, et al. Clinilca trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studies. Alimen Pharmacol Ther. 2009;29:329–41.

    Article  CAS  Google Scholar 

  20. Lee KJ, Kim JH, Cho SW. Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2005;22:981–9.

    Article  PubMed  CAS  Google Scholar 

  21. Houghton LA, Fell C, Whorwell PJ, et al. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut. 2007;56:1218–25.

    Article  PubMed  CAS  Google Scholar 

  22. Gale JD. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. Adv Ther. 2009;26:519–30.

    Article  PubMed  CAS  Google Scholar 

  23. George AM, Meyers NL, Hickling RI. Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome – a multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting. Aliment Pharmacol Ther. 2008;27:830–7.

    Article  PubMed  CAS  Google Scholar 

  24. Andresen V, Camilleri M, Busciqlio IA, et al. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology. 2007;133:761–8.

    Article  PubMed  CAS  Google Scholar 

  25. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastsroenterol. 2009;15:1548–53.

    Article  CAS  Google Scholar 

  26. Brennan BP, Fogarty KV, Roberts JL, et al. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol. 2009;24:423–8.

    Article  PubMed  CAS  Google Scholar 

  27. Shen YA, Nahas R. Complementary and alternative medicine for treatment of irritable bowel syndrome. Can Fam Physician. 2009;55:143–8.

    PubMed  Google Scholar 

  28. Lembo AJ, Conboy L, Kelley JM. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol. 2009;104:1489–97.

    Article  PubMed  Google Scholar 

  29. Mikocka-Walus A, Turnbull D, Moulding N, et al. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. J Gastroenterol Hepatol. 2008;23:1137–43.

    Article  PubMed  Google Scholar 

  30. Hertig VL, Cain KC, Jarrett ME, Burr RL, Heitkemper MM. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome. Nurs Res. 2007;56:399–406.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dawn A. Marcus .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Marcus, D.A., Deodhar, A. (2011). Irritable Bowel Syndrome. In: Fibromyalgia. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1609-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1609-9_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1608-2

  • Online ISBN: 978-1-4419-1609-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics